Extended sensitivity for PK/PD and biomarker analysis using nanoliter-scale immunoassays

In this webinar presented on February 23, 2021 at the SelectScience Analytical Summit, Chris Fox introduces the extension of the microfluidic, nanoliter-scale Gyrolab® immunoassay platform sensitivity for PK and biomarker assays.


Talk Description:

Discovery and development of biotherapeutics requires robust immunoassays for quantification to support pharmacokinetic (PK) studies, as well as biomarker analysis. A microfluidic, flow-through platform with high reproducibility has extended assay sensitivity capabilities with a new CD consumable, the Gyrolab Bioaffy™ 4000 CD. Data demonstrating the improvement of assay dynamic range for PK and biomarker analysis will be presented, along with a novel approach to cytokine biomarker panel assay design.


Chris Fox 100Chris Fox
Application Scientist
Gyros Protein Technologies




If you have problems to view the webinar please contact


Please register to view the webinar